UNSPSC 51392207: Indanazoline

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51392207

Definition

This classification denotes an alpha-adrenergic agonist with the molecular formula C12H15N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L0U38EHD86, chemically known as 1h-imidazol-2-amine, n-(2,3-dihydro-1h-inden-4-yl)-4,5-dihydro- but generally known as indanazoline, which bears US NIH Compound Identifier 65979. European Medicines Agency schedules Indanazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08166MIG.

Read the full definition

The term INDANAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). INDANAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Indanazoline under HS 29332990 and SITC 51573. As of Q4 2014, INDANAZOLINE remains the US FDA Preferred Term for this commodity. Indanazoline bears US NLM identifiers UMLS ID C0063449 and NCI Concept Code C65908. SMILES: C1CC2C(C(C1)NC3=NCCN3)CCC2.

About UNSPSC 51392207

UNSPSC 51392207 Indanazoline is a Commodity code that captures pharmaceutical products used in emergency medical response and public health interventions, specifically opioid antagonists and drug deactivation systems procured by state and local health and safety agencies. The code reflects state and local governments' procurement of naloxone and related emergency medical supplies to support community health and overdose-response initiatives. Recent solicitations show county public health departments acquiring these products through competitive bidding to stock emergency response inventories and support harm-reduction programs.

Seminole County, Florida issued an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023. The procurement required vendors to submit unit pricing, include all shipping and delivery costs in proposals, maintain workers' compensation and general liability insurance, comply with E-Verify requirements, and satisfy drug-free workplace certification. The contract structure offered an initial two-year term with a one-year renewal option and included a three-month probationary period allowing termination at will. The solicitation notes potential FEMA funding, which introduces federal environmental compliance requirements such as adherence to the Clean Air Act and Federal Water Pollution Control Act. Activity under this code remains limited in the recent opportunities data provided, with only the Seminole County solicitation visible; geographic spread and issuing-body mix cannot be characterized from a single opportunity.

Quick answers

What is UNSPSC 51392207?

UNSPSC 51392207 is Indanazoline, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51392207?

UNSPSC 51392207 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51392207

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code